Arkolith/Insider Trading/IGC/Form 4

Grimaldi Claudia

DirectorIGC Pharma, Inc. (IGC) · full profile →Form 4 · filed Mar 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
4 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)83K—$0784K
Mar 13, 2024Option exercise(M)95K—$01.0M
Mar 13, 2024Option exercise(M)100K—$0942K
Mar 13, 2024Option exercise(M)58K—$0842K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2024Grant(A)550K—$0550K
Mar 13, 2024Grant(A)360K—$0360K
Mar 13, 2024Option exercise(M)95K—$0285K
Mar 13, 2024Option exercise(M)100K—$0200K
Mar 13, 2024Option exercise(M)58K—$058K
Mar 13, 2024Option exercise(M)83K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-24-000264) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML